VALEO news, videos and press releases
For more news please use our advanced search feature.
VALEO - More news...
VALEO - More news...
- Valeo Q1 2024 Sales - First-quarter sales of 5.4 billion euros, up 2% like for like
- Valeo announces its green bond issue for an amount of 850 million euros with maturity April 2030
- Valeo General Shareholders' Meeting 2024
- Implementation of the share buy-back program
- Valeo presents Valeo Racer, a new extended reality in-car gaming experience developed with Unity, at South by Southwest 2024
- Valeo atteint ses objectifs 2023 et se fixe pour objectif d’augmenter de plus de 60 % son résultat d’exploitation et sa génération de cash entre 2023 et 2025
- Valeo is taking you for a ride @ SXSW 2024
- Valeo Q3 2023 Sales
- Valeo announces the sale of its propulsion systems business in Russia to NPK Avtopribor
- Cancel and replaces - Valeo H1 2023 results
- Valeo H1 2023 results
- Valeo General Shareholders' Meeting 2023
- Availability of the 2022 Universal Registration Document
- C2A Security Partners with Valeo to Enhance Cybersecurity for the Software Defined Vehicle
- C2A Security Partners with Valeo to Enhance Cybersecurity for the Software Defined Vehicle
- VALEO PHARMA ENTERS INTO CANADIAN COMMERCIAL SERVICES AGREEMENT WITH VERU FOR SABIZABULIN IN HOSPITALIZED ADULT PATIENTS WITH COVID-19 AT HIGH RISK FOR ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
- VALEO PHARMA OBTAINS PUBLIC REIMBURSEMENT FOR ENERZAIR® BREEZHALER® AND ATECTURA® BREEZHALER® IN ONTARIO, MANITOBA AND NEW BRUNSWICK
- VALEO PHARMA'S HESPERCO™ NOW AVAILABLE AT LOBLAWS, HESPERIDIN COVID-19 CLINICAL TRIAL RESULTS SUBMITTED FOR PUBLICATION
- With its new generation LiDAR, Valeo makes autonomous mobility a reality
- Valeo - Invitation - See the invisible
- Valeo - Invitation - See the invisible
- Valeo - Invitation - See the invisible
- Valeo Pharma Obtains Public Reimbursement For Enerzair® Breezhaler® and Atectura® Breezhaler® In Alberta
- /C O R R E C T I O N from Source -- Valeo Pharma inc./
- Valeo Pharma Obtains Listings for Redesca in 700 Hospitals and Healthcare Facilities Across Canada
- Valeo Pharma Completes Negotiations with Pan-Canadian Pharmaceutical Alliance for Enerzair® Breezhaler® and Atectura® Breezhaler®
- Valeo Pharma Announces Additional Provincial Reimbursement Coverage for Redesca™ and Redesca HP™
- Valeo Pharma to Report Second Quarter 2021 Results and Hold Investors Conference Call / Webcast
- Valeo Pharma Announces Commercial Launch of Enerzair® Breezhaler® and Atectura® Breezhaler®
- Valeo Pharma Provides Update on Private Payer Reimbursement for Enerzair® Breezhaler® and Atectura® Breezhaler®